Muhammad Fawad Rasool

Global antibiotic consumption patterns through the lens of the WHO AWaRe framework: An umbrella review

Rimsha Sarwar, Muhammad Fawad Rasool, Brian Godman, Alian A. Alrasheedy et autres

This umbrella review evaluates global antibiotic consumption patterns using the WHO AWaRe framework. We conducted a systematic search in PubMed, ScienceDirect, and Google Scholar to identify systematic reviews and meta-analyses published between January 2000 and March 2025 reporting antibiotic consumption. Data extracted …

pk, Afrique du Sud, sa (code pays fourni par la source)

Exploring the Clinical Pharmacokinetics of Sitagliptin in Healthy and Diseased Populations: A Systematic Critical Review

Tahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, Faleh Alqahtani

PURPOSE: Sitagliptin is an incretin enhancer used for treating type 2 diabetes mellitus. This review examined the pharmacokinetics (PK) of sitagliptin in healthy and diseased subjects. METHODS: Articles related to sitagliptin PK were obtained by searching Google Scholar, PubMed, Cochrane Library, and …

pk, sa (code pays fourni par la source)

Development and Evaluation of Physiologically Based Pharmacokinetic (PBPK) Models to Investigate the Effect of CYP2D6 Polymorphism on Metoclopramide Systemic Exposure

Iqra Shahzad, Ammara Zamir, Muhammad Fawad Rasool, Amer S. Alali et autres

Background: Physiologically based pharmacokinetic (PBPK) modeling is a mechanistic tool used to predict how a drug moves through the body by incorporating real human physiology, including organ sizes, blood flows, tissue compositions, and enzyme activities. It has been widely employed to estimate …

pk, sa, cn (code pays fourni par la source)

Clinical pharmacokinetics of afatinib: A systematic review

Tehreem Ikram, Ammara Zamir, Abdul Majeed, Faleh Alqahtani et autres

pk, sa (code pays fourni par la source)

Synthesis, Characterization and Antibacterial Activity of DEAE-C Loaded Cefixime Nano-Particles Against Resistant Bacterial Strains

Muhammad Tayyub Kazam, Saman Arooj, Mahpara Tabassum, Hamid Saeed et autres

Exploring the clinical pharmacokinetics and pharmacodynamics of third-generation cephalosporin, a cefotaxime: a systematic review

Muhammad Zubair, Tahir Saleem, Ammara Zamir, Muhammad Fawad Rasool et autres

Cefotaxime is a third-generation cephalosporin that is used to treat susceptible bacterial infections. This systematic review provides an in-depth analysis of all pharmacokinetic (PK) and pharmacodynamic (PD) parameters of cefotaxime in humans. A systematic search was conducted using the search engines Google …

Exploring the clinical pharmacokinetics and pharmacodynamics of third-generation cephalosporin, a cefotaxime: a systematic review

Muhammad Zubair, Tahir Saleem, Ammara Zamir, Muhammad Fawad Rasool et autres

Cefotaxime is a third-generation cephalosporin that is used to treat susceptible bacterial infections. This systematic review provides an in-depth analysis of all pharmacokinetic (PK) and pharmacodynamic (PD) parameters of cefotaxime in humans. A systematic search was conducted using the search engines Google …

Exploring the clinical pharmacokinetics and pharmacodynamics of third-generation cephalosporin, a cefotaxime: a systematic review

Muhammad Zubaır, Tahir Saleem, Ammara Zamir, Muhammad Fawad Rasool et autres

Cefotaxime is a third-generation cephalosporin that is used to treat susceptible bacterial infections. This systematic review provides an in-depth analysis of all pharmacokinetic (PK) and pharmacodynamic (PD) parameters of cefotaxime in humans.A systematic search was conducted using the search engines Google Scholar, …

pk, sa (code pays fourni par la source)

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review

Tahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, Faleh Alqahtani

Empagliflozin is a potent, highly selective antihyperglycemic agent indicated for the treatment of adults with type 2 diabetes mellitus. This review aims to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) parameters of empagliflozin in healthy and diseased subjects. Google Scholar, PubMed, and …

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review

Tahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, Faleh Alqahtani

Empagliflozin is a potent, highly selective antihyperglycemic agent indicated for the treatment of adults with type 2 diabetes mellitus. This review aims to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) parameters of empagliflozin in healthy and diseased subjects. Google Scholar, PubMed, and …

pk, sa (code pays fourni par la source)

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review

Tahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, Faleh Alqahtani

Empagliflozin is a potent, highly selective antihyperglycemic agent indicated for the treatment of adults with type 2 diabetes mellitus. This review aims to evaluate the pharmacokinetic (PK) and pharmacodynamic (PD) parameters of empagliflozin in healthy and diseased subjects. Google Scholar, PubMed, and …

A systematic review on clinical pharmacokinetics and pharmacodynamics of antiangiogenic tyrosine kinase inhibitors (TKIs) with high TDM scores

Abdul Wasay Sherazi, Muhammad Fawad Rasool, Zheng Jiao, Faleh Alqahtani

Tyrosine kinase inhibitor (TKI) drugs are used to treat various cancer types. This systematic review evaluates the published pharmacokinetic (PK) and pharmacodynamic (PD) parameters of TKI drugs with high therapeutic drug monitoring (TDM) scores in humans. A comprehensive computerized literature search of …